Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibacterial spectrum of fosfomycin trometamol.

× No keyword cloud information.

13 in total

1. Characterization of a novel two-component regulatory system, HptRS, the regulator for the hexose phosphate transport system in Staphylococcus aureus.

Authors: Joo Youn Park; Jong Wan Kim; Bo Youn Moon; Juyeun Lee; Ye Ji Fortin; Frank W Austin; Soo-Jin Yang; Keun Seok Seo
Journal: Infect Immun Date: 2015-02-02 Impact factor: 3.441

2. Susceptibility testing quality control studies with fosfomycin tromethamine.

Authors: P C Fuchs; A L Barry; S D Brown
Journal: Eur J Clin Microbiol Infect Dis Date: 1997-07 Impact factor: 3.267

3. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.

Authors: Ching-Lan Lu; Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Lee-Jene Teng; John D Turnidge; Po-Ren Hsueh
Journal: Antimicrob Agents Chemother Date: 2011-06-13 Impact factor: 5.191

Review 4. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors: Ana Maria Rivera; Helen W Boucher
Journal: Mayo Clin Proc Date: 2011-12 Impact factor: 7.616

Review 5. Fosfomycin.

Authors: Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal: Clin Microbiol Rev Date: 2016-04 Impact factor: 26.132

Review 6. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

Authors: S S Patel; J A Balfour; H M Bryson
Journal: Drugs Date: 1997-04 Impact factor: 9.546

Antibacterial spectrum of fosfomycin trometamol.

1. Characterization of a novel two-component regulatory system, HptRS, the regulator for the hexose phosphate transport system in Staphylococcus aureus.

2. Susceptibility testing quality control studies with fosfomycin tromethamine.

3. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.

Review 4. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Review 5. Fosfomycin.

Review 6. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

7. Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones.

Review 8. Multidrug-resistant Gram-negative infections: what are the treatment options?

Review 9. Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis.

Review 10. Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance.